We target medical-use cannabis facilities for acquisition, including sale-leaseback transactions, with tenants that are licensed growers under long-term triple-net leases. We believe this industry is poised for significant growth in coming years, and we are focused on being a creative capital provider to this industry through the long-term ownership of cultivators’ mission-critical facilities.
We expect other states to approve medical-use cannabis in coming years as well, fueled by changing public attitudes in the United States. A recent poll by Quinnipiac University found that 89% of Americans support patient access to medical-use cannabis, if recommended by a doctor.
This follows a another poll by Harris, which found 81% of Americans support the legalization of cannabis for medical use. We see this as the perfect time to be bullish in this segment of the industry. Medical use cannabis is the safe zone in the marijuana industry. It comes under pharmaceutical products for specific medical ailments and use. Allowing such companies or investments to be considered non evasive to the community in the eyes of those against legalization, considering them ancillary cannabis companies or investments. Obviously our focus will be the medical use part of the industry to add that extra vail of protection to our investors investments.